KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Equity Ratio: 2009-2025

Historic Equity Ratio for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to 0.45.

  • Charles River Laboratories International's Equity Ratio fell 4.08% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year decrease of 4.08%. This contributed to the annual value of 0.46 for FY2024, which is 4.77% up from last year.
  • According to the latest figures from Q3 2025, Charles River Laboratories International's Equity Ratio is 0.45, which was up 2.14% from 0.44 recorded in Q2 2025.
  • Charles River Laboratories International's Equity Ratio's 5-year high stood at 0.47 during Q3 2024, with a 5-year trough of 0.34 in Q3 2021.
  • For the 3-year period, Charles River Laboratories International's Equity Ratio averaged around 0.44, with its median value being 0.44 (2025).
  • Its Equity Ratio has fluctuated over the past 5 years, first fell by 6.30% in 2021, then climbed by 22.05% in 2023.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Equity Ratio stood at 0.36 in 2021, then increased by 8.48% to 0.39 in 2022, then grew by 12.11% to 0.44 in 2023, then rose by 4.77% to 0.46 in 2024, then decreased by 4.08% to 0.45 in 2025.
  • Its Equity Ratio stands at 0.45 for Q3 2025, versus 0.44 for Q2 2025 and 0.42 for Q1 2025.